Li Wang

发表

High level of AKT activity is associated with resistance to MEK inhibitor AZD6244 (ARRY-142886)

Li Wang, John D. Minna, Lin Ji, 2009, Cancer biology & therapy.

Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer

K. Hunt, L. Su, Li Wang, 2004, Oncogene.

Eliminating Established Tumor in nu/nu Nude Mice by a Tumor Necrosis Factor-α-Related Apoptosis-Inducing Ligand–Armed Oncolytic Adenovirus

Wei Guo, B. Fang, Li Wang, 2006, Clinical Cancer Research.

Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer.

Jeffrey S. Morris, I. Shureiqi, B. Fang, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization.

J. Roth, S. Swisher, R. Mehran, 2019, American journal of cancer research.

Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignancies.

R. Stafford, S. Vedam, Jingfei Ma, 2020, Brachytherapy.

Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities

J. Roth, S. Swisher, M. Andreeff, 2017, Oncotarget.

A rapid and efficient method for purification of recombinant adenovirus with RGD-modified fibers

B. Fang, Li Wang, Shuhong Wu, 2008 .

A rapid and efficient method for purification of recombinant adenovirus with arginine-glycine-aspartic acid-modified fibers.

J. Roth, B. Fang, Li Wang, 2006, Analytical biochemistry.

KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations.

Jeffrey S. Morris, Jing Wang, J. Minna, 2020, American journal of cancer research.

Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.

Kwok-Kin Wong, L. Nie, Chia-Hung Chen, 2018, Cancer cell.

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells

J. Minna, J. Roth, S. Swisher, 2015, Oncotarget.

Oxidative stress in NSC-741909-induced apoptosis of cancer cells

Jinsong Liu, Peng Huang, B. Fang, 2010, Journal of Translational Medicine.

Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy

J. Roth, S. Swisher, D. Gibbons, 2018, Oncoimmunology.

Patient-Derived Xenografts From Lung Cancer and Their Potential Applications

Li Wang, Rongjia Zhang, B. Fang, 2017 .

IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non–Small Cell Lung Cancer Cells

J. Minna, J. Roth, S. Swisher, 2013, Molecular Cancer Therapeutics.

Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival

Xifeng Wu, J. Roth, S. Swisher, 2013, PloS one.

IGFBP 2 / FAK pathway is causally associated with dasatinib resistance in non-small Cell Lung Cancer Cells

J. Minna, J. Roth, S. Swisher, 2013 .

Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells.

Michael L. Wang, J. Minna, J. Roth, 2014, Journal of the National Cancer Institute.

Inhibiting JNK Dephosphorylation and Induction of Apoptosis by Novel Anticancer Agent NSC-741909 in Cancer Cells*

Yiling Lu, Jinsong Liu, B. Fang, 2009, The Journal of Biological Chemistry.

Tumor characteristics associated with engraftment of patient‐derived non–small cell lung cancer xenografts in immunocompromised mice

J. Roth, S. Swisher, J. Fujimoto, 2019, Cancer.

Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.

K. Shaw, J. Roth, S. Swisher, 2015, Cancer letters.

Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.

Jing Wang, J. Minna, J. Roth, 2018, Cancer research.

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

J. Roth, S. Swisher, B. Fang, 2018, Journal of Translational Medicine.

Generation of patient‐derived xenografts from fine needle aspirates or core needle biopsy

S. Swisher, C. Dinney, J. Gershenwald, 2017, Surgery.

Treatment of Radioresistant Stem-Like Esophageal Cancer Cells by an Apoptotic Gene-Armed, Telomerase-Specific Oncolytic Adenovirus

Joe Y. Chang, R. Komaki, B. Fang, 2008, Clinical Cancer Research.

Antitumor Activity of a Novel Oncrasin Analogue Is Mediated by JNK Activation and STAT3 Inhibition

B. Fang, Li Wang, M. Hollingshead, 2011, PloS one.

Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma

B. Fang, Li Wang, Shuhong Wu, 2018, Molecular Cancer Therapeutics.

Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380

K. Baggerly, J. Roth, S. Swisher, 2014, Oncotarget.

Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities.

Jinsong Liu, B. Fang, Li Wang, 2011, Journal of medicinal chemistry.

Antagonistic effect of flavonoids on NSC-741909-mediated antitumor activity via scavenging of reactive oxygen species.

B. Fang, Li Wang, Shuhong Wu, 2010, European journal of pharmacology.

Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)

Jinsong Liu, B. Fang, Li Wang, 2009, Molecular Cancer Therapeutics.

Researchstress in NSC-741909-induced apoptosis of cancer cells

Jinsong Liu, Peng Huang, B. Fang, 2010 .

Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer.

G. Hortobagyi, M. Hung, W. Xia, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells.

Edward S. Kim, J. Minna, J. Roth, 2012, Biochemical Pharmacology.

Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380.

J. Roth, S. Swisher, B. Fang, 2014, Bioorganic & medicinal chemistry.

Antagonistic effect of flavonoids on NSC-741909-mediated antitumor activity via scavenging of reactive oxygen species.

B. Fang, Li Wang, Shuhong Wu, 2010, European journal of pharmacology.

Treatment of Radioresistant Stem-Like Esophageal Cancer Cells by an Apoptotic Gene-Armed, Telomerase-Specific Oncolytic Adenovirus

Joe Y. Chang, R. Komaki, B. Fang, 2008, Clinical Cancer Research.